Sign in
4

Changes in Ownership

Seaport Therapeutics, Inc. Filed Acc 0001193125-26-204471

Chief Scientific Officer acquired 3,351 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Chen Michael Cunyuan · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-04 Conversion : show line 1 in the form +3,351 3,351 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-30 Grant or award : show line 2 in the form Stock Option (Right to Buy) +63,680 63,680 D
2026-05-04 Conversion : show line 3 in the form Series B Preferred Stock −10,526 0 D
Loading xslF345X06/ownership.xml…